SCHEMBL30748375

SCHEMBL30748375

N#Cc1cc(C#N)cc(CC=O)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 2/20 0.35
TTR P02766 2/20 0.33
ALB P02768 2/20 0.33
LOXL2 Q9Y4K0 2/20 0.33
CYP2A6 P11509 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
GLA P06280 1/20 0.33
HTT P42858 1/20 0.32
GPR35 Q9HC97 1/20 0.31
ADRA1D P25100 1/20 0.31
CYP11B1 P15538 1/20 0.31
CYP11B2 P19099 1/20 0.31
FFAR1 O14842 1/20 0.31
CA1 P00915 2/20 0.31
CA2 P00918 2/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
IDO1 P14902 1/20 0.31
MEP1A Q16819 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29813213 0.86 ADRA1D (0.45) VCAM1ADRA1DMAOAMAOB
SCHEMBL26966869 0.86 ADRA1D (0.45) VCAM1ADRA1DMAOAMAOB
SCHEMBL253203 0.79 GLA (0.51) GLACYP11B1CYP11B2FFAR1MEP1A
SCHEMBL30646949 0.79 GLA (0.51) GLACYP11B1CYP11B2FFAR1MEP1A
SCHEMBL2240175 0.76 LOXL2 (0.54) LOXL2CYP2A6HTTCYP11B1CYP11B2
SCHEMBL6740528 0.75 TTR (0.41) VCAM1TTRALBLOXL2CYP2A6
SCHEMBL2163202 0.74 XDH (0.38) VCAM1TTRALBLOXL2CYP2A6
SCHEMBL21275388 0.74 KIF11 (0.33) VCAM1FFAR1
SCHEMBL1338614 0.74 TTR (0.33) VCAM1TTRALBCYP2A6MEN1
SCHEMBL1542913 0.74 LOXL2 (0.41) VCAM1TTRALBLOXL2CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4573077-A1 APOL1 INHIBITORS AND METHODS OF USE Maze Therapeutics, Inc. (US) 2025-06-25 EP disclosed
WO-2024249252-A1 METHODS OF USING APOL1 INHIBITORS MAZE THERAPEUTICS, INC. (US) 2024-12-05 WO disclosed
WO-2024040235-A1 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2024-02-22 WO disclosed